Aztreonam

Anaheim to Host World's Largest Cystic Fibrosis Medical Meeting

...d noncompetitive environment. Key topics will include: -- Advancements in drug discovery and development and the importance of clinical trials; -- aztreonam lysine for inhalation as a potential new CF therapy; -- Quality improvement and patient outcomes; -- The importance of newborn screening; and -- Se...

Aztreonam in Medical Technology

PARI's eFlow Included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation

MONTEREY, Calif., Nov. 26 /PRNewswire/ -- PARI Pharma's eFlow electronic nebulizer was included in Gilead's (Nasdaq: GILD ) recent New Drug Application (NDA) submittal to the U.S. Food and Drug Administration (FDA) for marketing approval of aztreonam lysine for inhalation (75 mg three times d...

Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

FOSTER CITY, Calif.--(BUSINESS WIRE)--May 29, 2007 - Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its Phase III AIR-CF1 (CP-AI-007) study of aztreonam lysine for inhalation for the treatment of people with cystic fibrosis (CF) who have pulmonary Pseudomonas aeruginosa (P. aeruginosa) me...

Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis

...c mean of the MIC in levofloxacin treated isolates increased less than two fold under anaerobic conditions, whereas tobramycin, amikacin and aztreonam treated isolates increased 4-7 fold under anaerobic conditions. This implies that MP-376 may retain its potency in anaerobic environments i...

Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections

...ed patients had a clinical cure rate of 91.6% compared to a vancomycin plus aztreonam clinical cure rate of 92.7% at test-of-cure (TOC) visit in the clinically e...d a microbiological eradication rate of 92.4% compared to a vancomycin plus aztreonam rate of 93.6% for all pathogens when used as treatment for cSSSI. The cefta...

Promising Cystic Fibrosis Compound on Track for Development

...e of Corus Pharmaceutical Company last year, acquired the rights to develop aztreonam lysine as an inhalation product to treat Pseudomonas aeruginosa infections. The company has said it will submit its new drug application (NDA) for aztreonam lysine to the FDA by the end of 2007. In the meantime, Gilead recently anno...

Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

... results of its Phase III AIR-CF2 study evaluating aztreonam lysine for inhalation, an antibiotic, in patients ...inosa). In the study, a 28-day treatment course of aztreonam lysine significantly improved the time to need for...ety and efficacy of a 28-day treatment course with aztreonam lysine for inhalation following a 28-day treatment...

Aztreonam in Medical Products

Antibiotic Level, Aztreonam

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Aztreonam in Biological Technology

Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush

...as a member of the scientific teams that developed a portfolio of leading hospital antibiotics including levofloxacin (Levaquin), doripenem (Doribax). aztreonam (Azactam) and piperacillin-tazobactam (Zozyn). Dr. Bush received her Ph.D. from the Indiana University Chemistry Department in 1970 and has s...

Horizon Therapeutics Announces Senior Management Appointments

...sed by Gilead Sciences, Inc. and was most recently vice president of operations at Corus where he was integral in the development and manufacturing of aztreonam lysinate for inhalation (AI). Additionally, he supervised the formulation and development of three additional drug candidates. Prior to Corus, ...

Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA

...feriority versus the combination of vancomycin and aztreonam in the treatment of complicated skin and skin stru...lar to those of the combination of vancomycin plus aztreonam (91.8% vs. 92.5%). MRSA eradication rates were als...cacy and Safety of Ceftaroline vs. Vancomycin plus aztreonam in Complicated Skin and Skin Structure Infections ...

Aztreonam in Biological Dictionary

Antibiotic

...icians. ... When is it okay for me to take antibiotics ? ... Information about antibiotic in the free online English dictionary and ... Azactam, aztreonam - an antibiotic (trade name Azactam) used against severe ... Antibiotic overuse is discussed. Dr. Greene explains when antibiotics should or ...